IFN-γ and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease

Autor:	Ramirez-Montagut, T., Chow, A., Kochman, A. A., Smith, O. M., Suh, D., Sindhi, H., Sydney Lu, Borsotti, C., Grubin, J., Patel, N., Terwey, T. H., Kim, T. D., Heller, G., Murphy, G. F., Liu, C., Alpdogan, O., Den Brink, M. R. M.
Zdroj:	Scopus-Elsevier Memorial Sloan Kettering Cancer Center
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a27125007265e07608efffcc8207cc79 http://www.scopus.com/inward/record.url?eid=2-s2.0-34548605451&partnerID=MN8TOARS Zobrazit plný text záznamu